Two Sigma Advisers’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-11,900
Closed -$152K 2898
2021
Q4
$152K Sell
11,900
-13,894
-54% -$176K ﹤0.01% 2354
2021
Q3
$352K Sell
25,794
-9,206
-26% -$128K ﹤0.01% 2050
2021
Q2
$564K Buy
+35,000
New +$480K ﹤0.01% 1899

Other funds holding TELA

Two Sigma Advisers's TELA Position: Q1 2022 in Review

Two Sigma Advisers sold out of TELA Bio (TELA) in Q1 2022, closing a stake of 11,900 shares — an estimated $152K sold.

Two Sigma Advisers first reported a position in TELA in Q2 2021 and held it in 3 quarters. The position peaked at $564K in Q2 2021. 30 funds tracked by Wall St. Rank hold TELA as of Q1 2022.

  • Two Sigma Advisers reported no remaining TELA Bio position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 11,900 TELA Bio shares in Q1 2022, an estimated $152K.
  • Two Sigma Advisers first reported a position in TELA Bio in Q2 2021 and held it in 3 quarters.
  • Two Sigma Advisers's TELA Bio position peaked at $564K in Q2 2021.
  • 30 funds tracked by Wall St. Rank held TELA Bio as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.